List of Curis (company) patents

Patents where

Current Assignee

Name

Curis (company)

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11597732 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety		Curis (company)	Curis (company)	United States Patent and Trademark Office	11597732	March 7, 2023
‌ US Patent 11040948 Crystal forms of immunomodulators	Patent 11040948 was granted and assigned to Curis (company) on June, 2021 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	11040948	June 22, 2021
‌ US Patent 11643401 Crystal forms of immunomodulators	Patent 11643401 was granted and assigned to Curis (company) on May, 2023 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	11643401	May 9, 2023
‌ US Patent 8357368 Methods of treating pancreatic or liver cancer using hedgehog antagonists	Patent 8357368 was granted and assigned to Curis (company) on January, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8357368	January 22, 2013
‌ US Patent 8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto	Patent 8354397 was granted and assigned to Curis (company) on January, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8354397	January 15, 2013
‌ US Patent 10336770 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety	Patent 10336770 was granted and assigned to Curis (company) on July, 2019 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	10336770	July 2, 2019
‌ US Patent 9657032 Phosphoinositide 3-kinase inhibitor with a zinc binding moiety	Patent 9657032 was granted and assigned to Curis (company) on May, 2017 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	9657032	May 23, 2017
‌ US Patent 9024024 Quinazoline based EGFR inhibitors containing a zinc binding moiety	Patent 9024024 was granted and assigned to Curis (company) on May, 2015 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	9024024	May 5, 2015
‌ US Patent 8461157 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety	Patent 8461157 was granted and assigned to Curis (company) on June, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8461157	June 11, 2013
‌ US Patent 9725461 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety	Patent 9725461 was granted and assigned to Curis (company) on August, 2017 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	9725461	August 8, 2017
‌ US Patent 11234986 Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety	Patent 11234986 was granted and assigned to Curis (company) on February, 2022 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	11234986	February 1, 2022
‌ US Patent 8367663 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety	Patent 8367663 was granted and assigned to Curis (company) on February, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8367663	February 5, 2013
‌ US Patent 9630965 Fused amino pyridine as HSP90 inhibitors	Patent 9630965 was granted and assigned to Curis (company) on April, 2017 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	9630965	April 25, 2017
‌ US Patent 9040556 Fused amino pyridine as HSP90 inhibitors	Patent 9040556 was granted and assigned to Curis (company) on May, 2015 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	9040556	May 26, 2015
‌ US Patent 10758518 Compounds and compositions for treating hematological disorders		Curis (company)	Curis (company)	United States Patent and Trademark Office	10758518	September 1, 2020
‌ US Patent 7928136 Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety	Patent 7928136 was granted and assigned to Curis (company) on April, 2011 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	7928136	April 19, 2011
‌ US Patent 8426419 Tyrosine kinase inhibitors containing a zinc binding moiety	Patent 8426419 was granted and assigned to Curis (company) on April, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8426419	April 23, 2013
‌ US Patent 8410061 Functional antagonists of hedgehog activity	Patent 8410061 was granted and assigned to Curis (company) on April, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8410061	April 2, 2013
‌ US Patent 10676482 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety		Curis (company)	Curis (company)	United States Patent and Trademark Office	10676482	June 9, 2020
‌ US Patent 8119616 Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety	Patent 8119616 was granted and assigned to Curis (company) on February, 2012 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8119616	February 21, 2012
‌ US Patent 8691820 CDK inhibitors	Patent 8691820 was granted and assigned to Curis (company) on April, 2014 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8691820	April 8, 2014
‌ US Patent 8906909 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety	Patent 8906909 was granted and assigned to Curis (company) on December, 2014 by the United States Patent and Trademark Office.	Curis (company)	Curis (company)	United States Patent and Trademark Office	8906909	December 9, 2014
‌ US Patent 8722703 Fused amino pyridines for the treatment of brain tumors	Patent 8722703 was granted and assigned to Curis (company) on May, 2014 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8722703	May 13, 2014
‌ US Patent 8455506 Quinazoline based EGFR inhibitors containing a zinc binding moiety	Patent 8455506 was granted and assigned to Curis (company) on June, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8455506	June 4, 2013
‌ US Patent 8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling	Patent 8486400 was granted and assigned to Curis (company) on July, 2013 by the United States Patent and Trademark Office.		Curis (company)	United States Patent and Trademark Office	8486400	July 16, 2013

Results per page:

52 results

0 selected

52 results

0 selected